Experimental model and immunohistochemical comparison of U87 human glioblastoma cell xenografts on the chicken chorioallantoic membrane and in rat brains

Anticancer Research

Volumn 30, Issue 12, 2010, Pages 4851-4860

  Strojnik, Tadej ^a   Kavalar, Rajko ^a   Barone, Tara A ^b   Plunkett, Robert J ^b  

^a UNIVERSITY MEDICAL CENTRE MARIBOR   (Slovenia)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Animal cancer models; Cell xenografts; Chick embryo; Glioblastoma; Immunohistochemistry; Rodent model; Tumour markers

Indexed keywords

CD68 ANTIGEN; EOSIN; GLIAL FIBRILLARY ACIDIC PROTEIN; HEMATOXYLIN; KALLIKREIN; KI 67 ANTIGEN; PROTEIN P53; PROTEIN S 100; SYNAPTOPHYSIN; TUMOR MARKER; VASCULOTROPIN; VIMENTIN;

ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CD3+ T LYMPHOCYTE; CELL CULTURE; CELL SUSPENSION; CHICKEN; CHORIOALLANTOIS; EMBRYO; EXPERIMENTAL STUDY; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INOCULATION; LEUKOCYTE COUNT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR XENOGRAFT;

ADULT; ANIMALS; BRAIN; BRAIN NEOPLASMS; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; DISEASE MODELS, ANIMAL; FEMALE; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM TRANSPLANTATION; RATS; RATS, NUDE; SPHEROIDS, CELLULAR; TRANSPLANTATION, HETEROLOGOUS;

EID: 78751520909     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Daumas-Duport C, Scheithauer BW and Kelly T: A histologic and cytologic method for the spatial definition of gliomas. Mayo Clin Proc 62: 435-439, 1987.
2. Silbergeld DL and Chicoine MR: Isolation and characterization of human malignant glioma cells from histologically normal brain. J Neurosurg 56: 525-531, 1997.
3. Deorah S, Lynch CF, Sibenaller ZA and Ryken TC: Trends in brain cancer incidence and survival in the United States: surveillance, epidemiology, and end results program, 1973 to 2001. Neurosurg Focus 20: 1-7, 2006.
4. Pilkington GJ, Bjerkvig R, De Ridder L and Kaaijk P: In vitro and in vivo models for the study of brain tumour invasion. Anticancer Res 17: 4107-4110, 1997.
5. Dai C and Holland EC: Glioma models. Biochim Biophy Acta 1551: M19-M27, 2001.
6. Holland EC, Celestino J, Dai C, Schaefer L, Sawaya RE and Fuller GN: Astrocytes give rise to oligodendrogliomas and astrocytomas after gene transfer of polyoma virus middle T antigen in vivo. Nat Genet 25: 55-57, 2000.
7. Reilly KM, Loisel DA, Branson RT, McLaughlin ME and Jacks T: Nf1; Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects. Nat Genet 26: 109-113, 2000.
8. Hagedorn M, Javerzat S, Gilges D, Meyre A, de Lafarge B, Eichmann A and Bikfalvi A: Accessing key step of human tumour progression in vivo by using an avian embryo model. PNAS 102: 1643-1648, 2000.
9. Chambers AF, Wilson SM, Tuck AB, Denhardt GH and Cairncross JG: Comparison of metastatic properties of a variety of mouse, rat, and human cells in assay in nude mice and chick embryos. In Vivo 4: 215-219, 1990.
10. Chambers AF, Denhardt GH, Wilson SM and Cairncross JG: Malignant properties of P635 glioma are independent of glial fibrillary acidic protein expression. J Neurooncol 11: 43-48, 1991.
11. Ossowski L and Reich E: Experimental model for quantitative study of metastasis. Cancer Res 40: 2300-2309, 1980.
12. Fogh J, Wright WC and Loveless JD: One hundred and twentyseven cultured human tumour cell lines producing tumours in nude mice. J Natl Cancer Inst 59: 221-226, 1977. (Pubitemid 8144854)
13. Ponten J and Macintyre EH: Long-term culture of normal and neoplastic human glia. Acta Pathol Microbiol Scand 74: 465-486, 1968.
14. Olopade OI, Jenkins RB, Ransom DT, Malik K, Pomykala H, Nabori T, Cowan JM, Rowler JD and Diaz MO: Molecular analysis of deletions of the short arm of Chromosom 9 in human gliomas. Cancer Res 52: 2523-2529, 1992.
15. Plunkett RJ, Lis A, Barone TA, Fronckowiak MD and Greenberg SJ: Hormonal effects on glioblastoma multiforme in the nude rat model. J Neurosurg 90: 1072-1077, 1999.
16. Leung DW, Cachianes G, Kuang WJ, Goeddel DV and Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246: 1306-1309, 1989.
17. Burstone MS: Enzyme Histochemistry. New York: Academic Press, 1962.
18. San-Galli F, Vrignaud P, Robert J and Cohadon P: Assessment of the experimental model of transplanted C6 glioblastoma in Wistar rats. J Neuro Oncol 7: 299-304, 1989.
19. Peterson DL, Sheridan MD and Brown WE: Animal models for brain tumours: historical perspectives and future directions. J Neurosurg 80: 865-876, 1994.
20. Pilkington GJ and Lantos PL: Pathology of experimental brain tumours. In: Neurooncology, Primary malignant brain tumours. Thomas DGT (ed.). London: Edward Arnold, pp. 5176, 1990.
21. Crafts D and Wilson CB: Animal models for brain tumors. Natl Cancer Inst Monogr 46: 11-17, 1977.
22. Scott R, Hall P and Haldane J: A comparison of immunohistochemical markers of cell proliferation with experimentally determined growth fraction. J Clin Pathol 165: 173-178, 1991.
23. Wilson G, Saunders M and Dische S: Direct comparison of bromodeoxyuridine and Ki-67 labeling indices in human tumours. Cell Prolif 29: 141-152, 1996.
24. Halvorsen OJ, Haukaas S, Hoisaeter PA and Akslen LA: Maximum Ki-67 staining in prostate cancer provides independent prognostic information after radical prostatectomy. Anticancer Res 21: 4071-4076, 2001.
25. Cunningham JM, Kimmel DW, Scheithauer BW, O'Fallon JR, Novotný PJ and Jenkins RB: Analysis of proliferation markers and p53 expression in gliomas af astrocytic origin: relationships and prognostic value. M/J Neurosurg 56: 121-130, 1997.
26. Newcomb EW, Madonia WJ, Pisharody S, Lang FF, Koslow M and Miller DC: A correlative study of p53 protein alteration and p53 gene mutation in glioblastoma multiforme. Brain Pathology 3: 229-235, 1993.
27. Balčioniené N, Tamašauskas A, Valanč iOté A, Deltuva V, Vaitiekaitis G, Gudinavičiené I, Weis J and von Keyserlingk DG: Histology of human glioblastoma transplanted on chicken chorioallantoic membrane. Medicina (Kaunas) 2: 123-131, 2009.
28. Dahl D, Rueger DC and Bignami A: Vimentin, the 57,000 molecular weight protein of fibroblast filaments, is the major cytoskeletal component in immature glia. Eur J Cell Biol 90: 191-196, 1981. (Pubitemid 11009494)
29. Dahl D: The vimentin-GFAP protein transition in rat neuroglia cytoskeleton occurs at the time of myelination. J Neurosci Res 6: 741-748, 1981.
30. Lazarides E: Intermediate filaments: a chemically heterogeneous, developmentally regulated class of proteins. Annu Rev Biochem 51: 219-250, 1982.
31. Herpers MJHM, Ramaekers FCS, Aldeweireldt J, Moesker O and Slooff J: Co-expression of glial acidic protein- and vimentintype intermediate filaments in human astrocytomas. Acta Neuropathol 70: 333-339, 1996.
32. Sedeghat F and Notopoulos A: S100 protein family and its application in clinical practice. Hippokratia 12: 198-204, 2008.
33. Sen J and Belli A: S100B in neuropathologic states: the CRP of the brain? J Neurosci Res 55: 1373-1380, 2007.
34. Bressler J, Smith BH and Kornblith PL: Tissue culture techniques in the study of human gliomas. In: Neurosurgery. Wilkins RH (ed.). New York: Mc Graw Hill, pp. 542-548, 1985.
35. Bierer BE, Emerson SG, Antin J, Maziarz R, Rappeport JM, Smith BR and Burakoff SJ: Regulation of cytotoxic T lymphocyte-mediated graft rejection following bone marrow transplantation. Transplan 46: 835-839, 1988.
36. Fang D, Nguyen TK, Leishear K, Finko R, Kulo AN, Hotz S, Van Belle PA, Xu X, Elder DE and Herlyn M: A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res 65: 9328-9337, 2005.
37. Hall BM, Dorsch S and Roser B: The cellular basis of allograft rejection in vivo. J Exp Med 148: 878-889, 1978.
38. Schwechheimer K, Wiedenmann B and Franke WW: Synaptophysin: A reliable marker for medulloblastomas. Virchows Archiv 411: 53-59, 1987.
39. McCormick D: Secretion of Cat B by human gliomas in vitro. Neuropatho Appl Neurobiol 19: 146-151, 1993.
40. Sivaparvathi M, Sawaya R, Wang SW, Rayford A, Yamamoto M, Liotta LA, Nicolson LA and Rao JS: Overexpression and localization of Cat B during the progression of human gliomas. Clin Exp Metastasis 13: 49-56, 1995.
41. Rempel SA, Rosenblum ML, Mikkelsen T, Yan PS, Ellis KD, Golembieski WA, Sameni M, Rozhin J, Ziegler G and Sloane BF: Cat B expression and localization in glioma progression and invasion. Cancer Res 54: 6027-6031, 1994.
42. Mikkelsen T, Yan PS, Ho KL, Sameni M, Sloane BF and Rosenblum ML: Immunolocalization of Cat B in human glioma: implications for tumor invasion and angiogenesis. J Neurosurg 5i: 285-290, 1995.
43. Strojnik T, Kos J, Židanik B, Golouh R and Lah T: Cathepsin B immunohistochemical staining in tumor and endothelial cells is a new prognostic factor for survival in patients with brain tumors. Clin Can Res 5: 559-567, 1999.
44. Strojnik T, Kavalar R, Trinkaus M and Lah TT: Cathepsin L in glioma progression: comparison with cathepsin B. Cancer Det Prev 29: 448-455, 2005.
45. Hulette CM, Downev BT and Burger PC: Macrophage markers in diagnostic neuropathology. Am J Surg Pathol 16: 493-499, 1992.
46. Rossi ML, Hughes JT, Esiri MM, Coakham HB and Brownwell DB: Immunohistological study of mononuclear cell infiltrate in malignant gliomas. Acta Neuropathol 74: 269-277, 1987.
47. Leenstra S, Das PK, Troost D, de Boer OJ and Bosch DA: Human malignant astrocytes express macrophage phenotype. J Neuroimmunol 56: 17-25, 1995.
48. Strojnik T, Kavalar R anf Lah TT: Experimental model and immunohistochemical analyses of U87 human glioblastoma cell xenografts in immunosuppressed rat brains. Anticancer Res 26: 2887-2900, 2006. (Pubitemid 44161777)
49. Hendriksen EM, Span PN, Schuuring J, Peters JP, Sweep FC, van der Kogel AJ and Bussink J: Angiogenesis, hypoxia and VEGF expression during tumour growth in a human xenograft tumour model. Microvasc Res 77: 96-103, 2009.
50. Fossati G, Ricevuti G, Edwards SW, Walker C, Dalton A and Rossi ML: Neutrophil infiltration into human gliomas. Acta Neuropathol 95: 349-354, 1999.